Correlogic provides research and development tools and support services to the pharmaceutical, research and diagnostic communities. Correlogic’s patented software makes it possible to identify proteomic bio-markers and other complex biomolecular relationships. This technology can be used for pinpointing early indicators of various diseases. Through toxicity evaluation, it can substantially reduce the time-to-market for new drugs.